View Item 

Show simple item record

Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer

dc.contributor.authorLanga, Kenneth M.en_US
dc.contributor.authorFendrick, A. Marken_US
dc.contributor.authorChernew, Michael E.en_US
dc.contributor.authorKabeto, Mohammed U.en_US
dc.contributor.authorPaisley, Kerry L.en_US
dc.contributor.authorHayman, James A.en_US
dc.date.accessioned2010-06-01T20:30:02Z
dc.date.available2010-06-01T20:30:02Z
dc.date.issued2004-03en_US
dc.identifier.citationLanga, Kenneth M.; Fendrick, A. Mark; Chernew, Michael E.; Kabeto, Mohammed U.; Paisley, Kerry L.; Hayman, James A. (2004). "Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer." Value in Health 7(2): 186-194. <http://hdl.handle.net/2027.42/73612>en_US
dc.identifier.issn1098-3015en_US
dc.identifier.issn1524-4733en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73612
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15164808&dopt=citationen_US
dc.description.abstractObjective:  There is currently limited information regarding the out-of-pocket expenditures (OOPE) for medical care made by elderly individuals with cancer. We sought to quantify OOPE for community-dwelling individuals age 70 or older with: 1) no cancer (No CA), 2) a history of cancer, not undergoing current treatment (CA/No Tx), and 3) a history of cancer, undergoing current treatment (CA/Tx). Methods:  We used data from the 1995 Asset and Health Dynamics Study, a nationally representative survey of community-dwelling elderly individuals. Respondents identified their cancer status and reported OOPE for the prior 2 years for: 1) hospital and nursing home stays, 2) outpatient services, 3) home care, and 4) prescription medications. Using a multivariable two-part regression model to control for differences in sociodemographics, living situation, functional limitations, comorbid chronic conditions, and insurance coverage, the additional cancer-related OOPE were estimated. Results:  Of the 6370 respondents, 5382 (84%) reported No CA, 812 (13%) reported CA/No Tx, and 176 (3%) reported CA/Tx. The adjusted mean annual OOPE for the No CA, CA/No Tx, and CA/Tx groups were $1210, $1450, and $1880, respectively ( P  < .01). Prescription medications ($1120 per year) and home care services ($250) accounted for most of the additional OOPE associated with cancer treatment. Low-income individuals undergoing cancer treatment spent about 27% of their yearly income on OOPE compared to only 5% of yearly income for high-income individuals with no cancer history ( P  < .01). Conclusions:  Cancer treatment in older individuals results in significant OOPE, mainly for prescription medications and home care services. Economic evaluations and public policies aimed at cancer prevention and treatment should take note of the significant OOPE made by older Americans with cancer.en_US
dc.format.extent113035 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Incen_US
dc.rightsISPORen_US
dc.subject.otherCanceren_US
dc.subject.otherCost of Illnessen_US
dc.subject.otherElderlyen_US
dc.subject.otherHealth-care Expendituresen_US
dc.subject.otherHealth Economicsen_US
dc.titleOut-of-Pocket Health-Care Expenditures among Older Americans with Canceren_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of General Medicine Department of Medicine, University of Michigan Medical School, Ann Arbor, MI, USA;en_US
dc.contributor.affiliationumInstitute for Social Research, University of Michigan, Ann Arbor, MI, USA;en_US
dc.contributor.affiliationumPatient Safety Enhancement Program, University of Michigan Health System, Ann Arbor, MI, USA;en_US
dc.contributor.affiliationumConsortium for Health Outcomes, Innovation, and Cost-Effectiveness Studies (CHOICES), University of Michigan, Ann Arbor, MI, USA;en_US
dc.contributor.affiliationumDepartment of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, USA;en_US
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartment of Veterans Affairs Center for Practice Management and Outcomes Research, Ann Arbor, MI, USA;en_US
dc.identifier.pmid15164808en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73612/1/j.1524-4733.2004.72334.x.pdf
dc.identifier.doi10.1111/j.1524-4733.2004.72334.xen_US
dc.identifier.sourceValue in Healthen_US
dc.identifier.citedreferenceGross D, Brangan N. Out-of-pocket spending on health care by Medicare beneficiaries age 65 and older: 1999 projections. Issue Brief (Public Policy Inst (Am Assoc Retired Pers) 1999: 1 – 14.en_US
dc.identifier.citedreferenceCrystal S, Johnson R, Harman J, Sambamoorthi U, Kumar R. Out-of-pocket health care costs among older Americans. J Gerontol Social Sci 2000; 55B: S51 – 62.en_US
dc.identifier.citedreferenceHwang W, Weller W, Ireys H, Anderson G. Out-of-pocket medical spending for care of chronic conditions. Health Aff 2001; 20: 267 – 78.en_US
dc.identifier.citedreferenceCassel CK, Besdine RW, Siegel LC. Restructuring Medicare for the next century: what will beneficiaries really need? Health Aff 1999; 18: 118 – 31.en_US
dc.identifier.citedreferenceSoumerai S, Ross-Degnan D. Inadequate prescription-drug coverage for Medicare enrollees—a call to action. N Engl J Med 1999; 340: 722 – 8.en_US
dc.identifier.citedreferenceAltman BM, Cooper PF, Cunningham PJ. The case of disability in the family: impact on health care utilization and expenditures for nondisabled members. Milbank Q 1999; 77: 39 – 75.en_US
dc.identifier.citedreferenceFederman AD, Adams AS, Ross-Degnan D, et al. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA 2001; 286: 1732 – 9.en_US
dc.identifier.citedreferenceSteinman M, Sands L, Covinsky K. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001; 16: 793 – 9.en_US
dc.identifier.citedreferenceFendrick A, Smith D, Chernew M, Shah S. A benefit-based copay for prescription drugs. patient contribution based on total benefits, not drug acquisition cost. Am J Manag Care 2001; 7: 861 – 7.en_US
dc.identifier.citedreferenceGross D, Alecxih L, Gibson M, et al. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries. Health Serv Res 1999; 34: 241 – 54.en_US
dc.identifier.citedreferenceHoffman C, Rice D, Sung H. Persons with chronic conditions: their prevalence and costs. JAMA 1996; 276: 1473 – 9.en_US
dc.identifier.citedreferenceBrookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998; 88: 1337 – 42.en_US
dc.identifier.citedreferenceKramarow E, Lentzner H, Rooks R, et al. Health and Aging Chartbook: Health, United States, 1999. Hyattsville (MD): National Center for Health Statistics, 1999.en_US
dc.identifier.citedreferenceYancik R, Ries LA. Aging and cancer in America: demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 2000; 14: 17 – 23.en_US
dc.identifier.citedreferenceKirschstein R. Disease-Specific Estimates of Direct and Indirect Costs of Illness and NIH Support [Internet]. Bethesda: NIH; 2000 [accessed 2003 Jan 23]. Available from: http://www1.od.nih.gov/osp/ospp/ecostudies/COIreportweb.htm.en_US
dc.identifier.citedreferenceHartunian NS, Smart CN, Thompson MS. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis. Am J Public Health 1980; 70: 1249 – 60.en_US
dc.identifier.citedreferenceHouts PS, Lipton A, Harvey HA, et al. Nonmedical costs to patients and their families associated with outpatient chemotherapy. Cancer 1984; 53: 2388 – 92.en_US
dc.identifier.citedreferenceSpector WD, Mor V. Utilization and charges for terminal cancer patients in Rhode Island. Inquiry 1984; 21: 328 – 37.en_US
dc.identifier.citedreferenceBrown ML. The national economic burden of cancer: an update. J Natl Cancer Inst 1990; 82: 1811 – 4.en_US
dc.identifier.citedreferenceBaker MS, Kessler LG, Urban N, Smucker RC. Estimating the treatment costs of breast and lung cancer. Med Care 1991; 29: 40 – 9.en_US
dc.identifier.citedreferenceBried EM, Scheffler RM. The financial stages of cancer in the elderly. Oncology (Huntingt) 1992; 6: 153 – 60.en_US
dc.identifier.citedreferenceRiley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 1995; 33: 828 – 41.en_US
dc.identifier.citedreferenceTaplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995; 87: 417 – 26.en_US
dc.identifier.citedreferenceLegorreta AP, Brooks RJ, Leibowitz AN, Solin LJ. Cost of breast cancer treatment: a 4-year longitudinal study. Arch Intern Med 1996; 156: 2197 – 201.en_US
dc.identifier.citedreferenceFireman BH, Quesenberry CP, Somkin CP, et al. Cost of care for cancer in a health maintenance organization. Health Care Financ Rev 1997; 18: 51 – 76.en_US
dc.identifier.citedreferenceBrown ML, Riley GF, Potosky AL, Etzioni RD. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care 1999; 37: 1249 – 59.en_US
dc.identifier.citedreferenceBloom BS, Knorr RS, Evans AE. The epidemiology of disease expenses. JAMA 1985; 253: 2393 – 7.en_US
dc.identifier.citedreferenceStommel M, Given CW, Given BA. The cost of cancer home care to families. Cancer 1993; 71: 1867 – 74.en_US
dc.identifier.citedreferenceGiven BA, Given CW, Stommel M. Family and out-of-pocket costs for women with breast cancer. Cancer Pract 1994; 2: 187 – 93.en_US
dc.identifier.citedreferenceClose P, Burkey E, Kazak A, et al. A prospective, controlled evaluation of home chemotherapy for children with cancer. Pediatrics 1995; 95: 896 – 900.en_US
dc.identifier.citedreferenceGuidry JJ, Aday LA, Zhang D, Winn RJ. Cost considerations as potential barriers to cancer treatment. Cancer Pract 1998; 6: 182 – 7.en_US
dc.identifier.citedreferenceAubert R, Herman W, Waters J, et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization: a randomized controlled trial. Ann Intern Med 1998; 129: 605 – 12.en_US
dc.identifier.citedreferenceWilson RS, Beckett LA, Bennett DA, et al. Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Arch Neurol 1999; 56: 1274 – 9.en_US
dc.identifier.citedreferenceMoore KA. Breast cancer patients’ out-of-pocket expenses. Cancer Nurs 1999; 22: 389 – 96.en_US
dc.identifier.citedreferenceSoldo BJ, Hurd MD, Rodgers WL, Wallace RB. Asset and health dynamics among the oldest old: an overview of the AHEAD Study. J Gerontol Psychol Sci Soc Sci 1997; 52B: 1 – 20.en_US
dc.identifier.citedreferenceHeeringa S, Hill DH, Howell D. Unfolding Brackets for Reducing Item Nonresponse in Economic Surveys. Health and Retirement Study Working Paper Series, No. 94–029. Ann Arbor: Survey Research Center, Institute for Social Research, The University of Michigan, 1995.en_US
dc.identifier.citedreferenceCao H. Impute: A SAS Application System for Missing Value Imputations [Internet]. Ann Arbor: Survey Research Center, Institute for Social Research, The University of Michigan, 2001 [last accessed 2003 Jan 23]. Available from: http://www.umich.edu/~hrswww/docs/userg/dr-007.pdf.en_US
dc.identifier.citedreferenceBrandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988; 1: 111 – 7.en_US
dc.identifier.citedreferenceLanga K, Chernew M, Kabeto MU, et al. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med 2001; 16: 770 – 8.en_US
dc.identifier.citedreferenceDuan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models for the demand for medical care. J Bus Econ Stat 1983; 1: 115 – 26.en_US
dc.identifier.citedreferenceManning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998; 17: 283 – 95.en_US
dc.identifier.citedreference42  Centers for Medicare and Medicaid Services. Medicare Deductible, Coinsurance and Premium Amounts, 2001 [Internet]. Baltimore: The Centers, 2004. Available from: http://custhelp.medicare.com/cgi-bin/medicare.cfg/php/enduser/std_alp.php.en_US
dc.identifier.citedreference43  National Cancer Institute. Overview of Cancer Prevalence Statistics [Internet]. Bethesda: The Institute, c2004 [last accessed 2003 Jan 23]. Available from: http://srab.cancer.gov/prevalence.en_US
dc.identifier.citedreferenceEppig F, Chulis G. Matching MCBS (Medicare Current Beneficiary Survey) and Medicare data: the best of both worlds. Health Care Financ Rev 1997; 18: 211 – 29.en_US
dc.identifier.citedreferenceThomas C, Ritter G, Wallack S. Growth in prescription drug spending among insured elders. Health Aff (Millwood) 2001; 20: 265 – 77.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1524-4733.2004.72334.x.pdf
Size:
110.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.